Article ; Online: Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities.
The Journal of allergy and clinical immunology
2020 Volume 146, Issue 4, Page(s) 786–789
| MeSH term(s) | Adenosine Monophosphate/administration & dosage ; Adenosine Monophosphate/adverse effects ; Adenosine Monophosphate/analogs & derivatives ; Adrenal Cortex Hormones/therapeutic use ; Alanine/administration & dosage ; Alanine/adverse effects ; Alanine/analogs & derivatives ; Amides/administration & dosage ; Amides/adverse effects ; Antibodies, Monoclonal, Humanized/administration & dosage ; Antibodies, Monoclonal, Humanized/adverse effects ; Antiviral Agents/administration & dosage ; Antiviral Agents/adverse effects ; Betacoronavirus/drug effects ; Betacoronavirus/immunology ; Betacoronavirus/pathogenicity ; COVID-19 ; Coronavirus Infections/drug therapy ; Coronavirus Infections/immunology ; Coronavirus Infections/virology ; Cytokine Release Syndrome/immunology ; Cytokine Release Syndrome/prevention & control ; Cytokine Release Syndrome/virology ; Drug Hypersensitivity/diagnosis ; Drug Hypersensitivity/drug therapy ; Drug Hypersensitivity/etiology ; Drug Hypersensitivity/immunology ; Humans ; Immunity, Innate/drug effects ; Immunologic Factors/administration & dosage ; Immunologic Factors/adverse effects ; Indoles/administration & dosage ; Indoles/adverse effects ; Infliximab/administration & dosage ; Infliximab/adverse effects ; Interleukin 1 Receptor Antagonist Protein/administration & dosage ; Interleukin 1 Receptor Antagonist Protein/adverse effects ; Pandemics ; Pneumonia, Viral/drug therapy ; Pneumonia, Viral/immunology ; Pneumonia, Viral/virology ; Pyrazines/administration & dosage ; Pyrazines/adverse effects ; Pyrazoles/administration & dosage ; Pyrazoles/adverse effects ; SARS-CoV-2 ; Severity of Illness Index |
|---|---|
| Chemical Substances | Adrenal Cortex Hormones ; Amides ; Antibodies, Monoclonal, Humanized ; Antiviral Agents ; Immunologic Factors ; Indoles ; Interleukin 1 Receptor Antagonist Protein ; Pyrazines ; Pyrazoles ; remdesivir (3QKI37EEHE) ; Adenosine Monophosphate (415SHH325A) ; ruxolitinib (82S8X8XX8H) ; umifenovir (93M09WW4RU) ; Infliximab (B72HH48FLU) ; favipiravir (EW5GL2X7E0) ; tocilizumab (I031V2H011) ; sarilumab (NU90V55F8I) ; Alanine (OF5P57N2ZX) |
| Keywords | covid19 |
| Language | English |
| Publishing date | 2020-07-22 |
| Publishing country | United States |
| Document type | Editorial ; Review |
| ZDB-ID | 121011-7 |
| ISSN | 1097-6825 ; 1085-8725 ; 0091-6749 |
| ISSN (online) | 1097-6825 ; 1085-8725 |
| ISSN | 0091-6749 |
| DOI | 10.1016/j.jaci.2020.07.008 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Uh III Zs.92: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.